基于移动应用程序的认知决策和记忆游戏可以提高轻度认知障碍的老年人的认知功能
Ampha Pumpho1, Rumpa Boonsinsukh2, Kitiyawadee Srisim1
1School of Integrative Medicine, Mae Fah Luang University, Chiang Rai, Thailand.
Frontiers in psychology
|October 27, 2025
概括
这项研究开发了一个移动游戏应用程序,以改善轻度认知障碍 (MCI) 的老年人认知功能. 应用程序培训显著提高了执行功能和处理速度,显示了认知康复的潜力.
科学领域:
- 老年学是一门学科.
- 认知科学 认知科学
- 人与计算机的交互
背景情况:
- 移动设备越来越多地用于支持轻度认知障碍 (MCI) 的老年人的记忆.
- 现有的移动应用程序缺乏用于评估执行功能和记忆等认知行为的图像处理.
- 需要交互式工具来评估和训练MCI的老年人的认知技能.
研究的目的:
- 开发一个使用图像处理进行认知训练的移动游戏应用程序.
- 为了调查这个应用程序是否能改善MCI老年人的认知表现.
- 评估执行功能,记忆,歧视,决策和处理速度的改善.
主要方法:
- 一项随机对照试验与42名被诊断为轻度MCI的老年人进行.
- 参与者被分为使用移动应用程序的干预组 (n=21) 和对照组 (n=21).
- 干预组每天训练30分钟,每周2天4周;所有参与者都接受了训练前和训练后的神经心理评估.
主要成果:
- 训练组在Stroop测试表现上显著改善 (增加正确答案,减少错误).
- 与对照组相比,训练组的听觉反应时间显著提高.
- 结果表明,手机应用程序干预的中等效果大小和临床上有意义的益处.
结论:
- 一个新的移动游戏应用程序显示出作为认知训练工具的希望.
- 该应用程序有效地针对和改善经历轻度认知障碍的老年人执行功能.
- 这项技术为老年人群中可访问的认知康复提供了潜在的途径.
更多相关视频
06:58Highlighting and Reducing the Impact of Negative Aging Stereotypes During Older Adults' Cognitive Testing
Published on: January 24, 2020
7.7K
07:31A Computerized Functional Skills Assessment and Training Program Targeting Technology Based Everyday Functional Skills
Published on: February 13, 2020
7.3K
相关概念视频
01:30Cognitive Development During Adulthood
768
Cognitive development continues throughout adulthood, undergoing significant shifts across early, middle, and late stages. Individual transition occurs from adolescent idealism to pragmatic and adaptable thinking in early adulthood. During this period, individuals learn to integrate personal beliefs with the recognition that other perspectives are equally valid. Exposure to the complexities of modern society, diverse experiences, and higher education contribute to this adaptive thought process,...
768
01:30Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists
544
Cognitive enhancers, also known as "smart drugs," are substances used to enhance memory, mental alertness, and concentration. These can be natural or synthetic and improve cognition in conditions like Alzheimer's disease (AD) and other neurodegenerative diseases. Some common examples include caffeine, amphetamines, methylphenidate, modafinil, arecoline, donepezil, vortioxetine, and piracetam. These enhancers work on the principle of synaptic plasticity and altered circuit function.
544
01:14Role of Cerebellum and Prefrontal Cortex in Memory
1.0K
The cerebellum, while traditionally associated with motor control, also plays a crucial role in memory, particularly in procedural memory, which involves learning motor tasks that become automatic through repetition. For example, studies have shown that when the cerebellum is damaged, individuals or animals lose the ability to learn conditioned motor responses, such as the conditioned eye-blink response in classical conditioning experiments with rabbits. This study demonstrates the...
1.0K
01:26Alzheimer's Disease: Overview
1.6K
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
1.6K
01:30Dementia
511
Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual....
The progression of dementia is generally gradual....
511
01:22Alzheimer's Disease: Treatment
806
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
806